Market Overview

Morning Market Movers

Share:
Related ALNY
It's A Big Weekend For Biotech
Alnylam and Collaborators Publish Pre-clinical Study Results in Nature Medicine on ALN-AT3
Related MRK
SunTrust's Latest Comments On Merck
Morgan Stanley's Major Pharma Q1 Preview
Bristol's Opdivo Scores Again Against Lung Cancer (Investor's Business Daily)

Alnylam Pharmaceuticals (NASDAQ: ALNY) rose 34.16% to $88.83 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

Rexahn Pharmaceuticals (NYSE: RNN) jumped 33.77% to $1.53. Rexahn Pharmaceuticals shares have jumped 235.29% over the past 52 weeks, while the S&P 500 index has gained 25.27% in the same period.

Rosetta Genomics (NASDAQ: ROSG) moved up 33.23% to $4.25 after the company reported that it has signed a master service provider agreement with a major global biopharmaceutical company.

Teche Holding Company (NYSE: TSH) shares jumped 28.44% to $70.00 after IBERIABANK (NASDAQ: IBKC) announced an agreement to acquire Teche Holding.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (ALNY + IBKC)

Around the Web, We're Loving...